Health Care
Health indices were flat Tuesday, as some stocks suffered from poor earnings and others benefited from good quarterly results.
Shares of Lexicon Pharmaceuticals(LXRX) dipped 3.1% after its first-quarter loss widened from the year-ago period. The company reported a first-quarter loss of 24 cents a share, or $18.9 million, compared to 17 cents a share, or $10.8 million, in the first quarter last year. The loss, which the company attributed to decreased revenue and increased research and development costs, actually beat the expectation of analysts surveyed by Thomson Financial, who foresaw a loss of 29 cents a share for the quarter. Shares fell 11 cents to $3.40. deCODE genetics(DCGN) shares also fell 1.9% after reporting deeper quarterly losses. After the market closed Monday, the company reported a $22.6 million net loss for the first quarter, compared to $20.3 million in the first quarter last year. Basic and diluted net loss per share was 37 cents, the same as the year-ago period. Analysts polled by Thomson Financial predicted a loss of 34 cents a share. deCODE on Tuesday announced positive results from a Phase I clinical trial for a heart attack prevention medication, but shares still fell 7 cents to $3.67 following the announcements. ViaCell(VIAC) also fell on first-quarter results. The company reported a $6.7 million net loss for the first quarter, or 17 cents a share, compared to a net loss of $5.1 million, or 13 cents a share, for the year-ago period. Three analysts surveyed by Thomson Financial estimated a loss of 12 cents a share for the quarter. Shares dropped 67 cents, or nearly 11%, to $5.59. Not every health care stock felt a loss Tuesday. Among those benefiting from earnings, Myriad Genetics(MYGN) announced a $5.9 million net loss for the third quarter of its 2007 fiscal year, or 14 cents per share, compared to $9.6 million, or a 24 cents a share loss in the same quarter last year. Shares lifted 85 cents, or 2.3%, to $37.40.TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn MoreOptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn MoreReal Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn MoreStocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn MoreTo begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
blog comments powered by Disqus
| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,393.45 | 1,310.33 | 2,827.34 | 15.81 |
Oil *
101.78
|
|
DOWN
26.41 |
DOWN
2.99 |
DOWN
10.02 |
DOWN
0.44 |
10 Yr
1.58%
SPDR Gold
151.62
|
|
-0.21%
|
-0.23%
|
-0.35%
|
-2.71%
|
Data delayed 20 minutes |


Connect with TheStreet